Advanced search×

Malignant proliferating trichilemmal cyst: a case report with review of literature.

Malays J Pathol 31(1):71-6 (2009) PMID 19694318

Proliferating trichilemmal cyst is a rapidly growing large cutaneous adnexal neoplasm occurring on the head and neck region of elderly women. Malignant transformation has rarely been reported in these lesions. We describe here a 85-year-old lady who presented with a large ulcerated growth over the scalp for one year duration. Incisional biopsy revealed proliferating trichilemmal cyst with malignant transformation. She underwent wide local excision of this growth. She is alive and without evidence of disease after 14 months of follow up. Because of limited number of cases reported in literature, management of malignant proliferating trichilemmal cyst is controversial. Treatment mainly entails wide local surgical excision. Many other adjuvant modalities have been tried. This paper presents the diagnosis and management of one case of malignant proliferating trichilemmal cyst followed by review of the literature.

Version: za2963e q8za3 q8zb0 q8zc7 q8zd1 q8ze4 q8zf2 q8zgc

Similar articles you may find interesting…

  1. Expression of the chemokines CXCL12 and CX3CL1 and their receptors in human nerve sheath tumors.

    Histol Histopathol (2013) PMID 23645563

    We firstly describe the expression of the chemokines CXCL12 (SDF-1) and CX3CL1 (fractalkine) and their respective receptors CXCR4, CXCR7 and CX3CR1 in different entities of human nerve sheath tumors and normal control tissues. Both ligands and their receptors are expressed in high to moderate levels...
  2. The Role of Radiation in Retroperitoneal Sarcomas.

    Curr Treat Options Oncol (2013) PMID 23649911

    We believe that postoperative radiotherapy should be reserved for very high-risk cases and should be treated to a dose of ≥60 Gy respecting normal tissue dose tolerances. An additional approach that we consider in the postoperative setting is close surveillance with consideration of preoperative...
  3. Expression of human full-length MUC1 inhibits the proliferation and migration of a B16 mouse melanoma cell line.

    Oncol Rep (2013) PMID 23633115

    We found that the growth of B16-MUC1 cells was significantly reduced in vitro. Therefore, in this study, we established two MUC1-positive clones, B16-MUC1 9-12 and B16-MUC1 9-23, and one empty vector control clone, B16-neo, to investigate the effects of MUC1 on the cancer-related characteristics of...